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Abstract
The transcription factor Miz-1 can either activate or repress gene expression in concert with binding partners including the
Myc oncoprotein. The genomic binding of Miz-1 includes both core promoters and more distal sites, but the preferred DNA
binding motif of Miz-1 has been unclear. We used a high-throughput in vitro technique, Bind-n-Seq, to identify two Miz-1
consensus DNA binding motif sequences—ATCGGTAATC and ATCGAT (Mizm1 and Mizm2)—bound by full-length Miz-1
and its zinc finger domain, respectively. We validated these sequences directly as high affinity Miz-1 binding motifs.
Competition assays using mutant probes indicated that the binding affinity of Miz-1 for Mizm1 and Mizm2 is highly
sequence-specific. Miz-1 strongly activates gene expression through the motifs in a Myc-independent manner. MEME-ChIP
analysis of Miz-1 ChIP-seq data in two different cell types reveals a long motif with a central core sequence highly similar to
the Mizm1 motif identified by Bind-n-Seq, validating the in vivo relevance of the findings. Miz-1 ChIP-seq peaks containing
the long motif are predominantly located outside of proximal promoter regions, in contrast to peaks without the motif,
which are highly concentrated within 1.5 kb of the nearest transcription start site. Overall, our results indicate that Miz-1
may be directed in vivo to the novel motif sequences we have identified, where it can recruit its specific binding partners to
control gene expression and ultimately regulate cell fate.
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Introduction
Miz-1 (ZBTB17) is a BTB/POZ (BR-C, ttk and bab/pox virus
and zinc-finger) domain-containing transcription factor that is
ubiquitously expressed throughout development. It was named via
an acronym for ‘‘Myc-interacting zinc finger’’ protein. Miz-1 was
originally functionally characterized as an inducer of growth arrest
[1]. Subsequently, Miz-1 was found to be critical in normal
development [2–4] and to play roles in human disease [5,6]. Miz-1
binds core promoters to activate target genes [7]. However, in the
presence of the basic helix-loop-helix transcription factor, Myc, the
function of Miz-1 shifts from activation to repression of
transcription. Myc and Miz-1 form a co-repressor complex,
silencing Miz-1 target genes including those associated with
differentiation and proliferation [8]. Thus, there exist both Myc-
dependent and Myc-independent functions of Miz-1. Still,
relatively little is known about the function of Miz-1 as a
transcriptional regulator.
Miz-1 can form a co-repressor complex with Myc by binding
through its Myc interaction domain, amino acids 683–715, to
silence Miz-1 target genes [1]. Myc-Miz interaction represses Miz-
1 gene activation at least in part by competing with the co-
activator p300 [7]. Recent genomics studies in stem cells also
support the hypothesis that the mechanism by which Myc
normally represses expression of differentiation genes, thereby
maintaining pluripotency and self-renewal, is at least in part
mediated via coordinated function with Miz-1 [9]. Alternately,
Miz-1 can form a co-activating complex with p300 and NPM,
activating target genes in a Myc-independent fashion [10,11].
Genome-wide chromatin immunoprecipitation-microarray (ChIP-
chip) analysis indicates that Myc occupies nearly 30% of Miz-1
targets in human embryonic stem cells (hESCs), while about 70%
of Miz-1 targets are not co-bound by Myc [9]. Interestingly and
contrary to previous studies that analyzed Miz-1 regulation of
specific candidate genes [7,8,10,12–14], which described Miz-1
binding localized to core promoter initiator element (Inr)
sequences in cancer cells, the global functional genomics analysis
in hESCs demonstrated that the distribution of Miz-1 binding is
predominantly localized to regions more than 1000 bases
upstream of the transcriptional start sites of target genes [9].
Conversely, a recent study reports Miz-1 binding predominantly at
proximal promoters in murine neural progenitor cells [15]. The
authors report a consensus binding motif in mouse cells, but so far
no specific DNA binding motif for Miz-1 in human cells has been
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identified. Thus, identification of human Miz-1 consensus DNA
binding motifs is central to understanding the genomic binding of
Miz-1 and its regulation of cellular biology.
Using a maltose binding protein (MBP) fusion protein tag
system, we employed Bind-n-Seq (BnS), an in vitro, high-
throughput DNA binding assay with Multiple EM for Motif
Elicitation (MEME) analysis to identify putative Miz-1 DNA
biding motifs de novo. The BnS method is an efficient and
comprehensive way to examine protein-DNA binding in a global,
unbiased manner [16]. BnS overcomes problems associated with
other motif-finding approaches including limitations on in vivo
detection and sensitivity, and time and labor-intensive in vitro
approaches. Instead, BnS employs massively parallel sequencing of
annealed oligonucleotides bound to MBP-tagged proteins.
We identified two novel putative Miz-1 consensus DNA binding
motifs, ATCGGTAATC (Mizm1) and ATCGAT (Mizm2),
through this BnS analysis. These motifs were then confirmed as
Miz-1-bound using electrophoretic mobility shift assays (EMSA).
Luciferase reporter assays demonstrated that Miz-1 can activate
gene expression via the motifs. These motifs are biologically
significant, bearing a strong resemblance to motifs that we
identified in recently published mouse and human Miz-1 ChIP-
seq data by another group. Interestingly, Mizm1 and Mizm2 are
also similar to motifs bound by Cut homeodomain proteins
including Cux1. However, we found that Cux1 and Miz-1 differ
substantially in their relative preference for each motif, indicating
that the similarity between the motifs is likely not functionally
relevant. In this work we have identified a preferred DNA motif
bound by Miz-1, and demonstrated its function in regulating
transcription, indicating a potential mechanism for the Inr-
independent genomic binding of Miz-1. Understanding the direct
genomic binding of Miz-1 will help to further our knowledge of the
transcriptional processes it directs and the effects on cell biology.
Materials and Methods
Recombinant Protein Expression and Purification
We generated a plasmid vector coding for an N-terminal fusion
of E. coli maltose binding protein (MBP) to full-length human Miz-
1 (MBP-Miz-1-FL) by restriction ligation of Miz-1 cDNA
generated from H9 hESC mRNA into pMAL-c5G (New England
Biolabs). To generate a fusion of MBP with the zinc finger domain
of Miz-1 (MBP-Miz-1-ZF), we cloned the sequence encoding the
13 C2H2 zinc fingers (nucleotides 805–2379) of human Miz-1 in
frame into a plasmid vector coding for an N-terminal MBP tag.
Isopropyl b-D-1-thiogalactopyranoside (IPTG) was used to induce
expression of MBP, MBP-Miz-1-FL, and MBP-Miz-1-ZF in E. coli
(BL21STAR). Five hours after IPTG induction, cells were
harvested by centrifugation (3500 rpm, 20 min, 4uC) and sonicat-
ed in Zinc Buffer A [ZBA; 10 mM Tris (pH 7.5), 90 mM KCl,
1 mM MgCl2, 90 mM ZnCl2, 5 mM DTT]. The resulting protein
lysate was cleared by centrifugation (20,000 rpm, 30 min, 4uC),
then incubated at 4uC with amylose-linked agarose beads (New
England Biolabs) for 20 min. Beads were washed with 10 column
volumes of ZBA. MBP, MBP-Miz-1-FL, or MBP-Miz-1-ZF was
eluted in 3 mL ZBA containing 10 mM maltose, then dialyzed in
2 L ZBA overnight to deplete free maltose using Slide-A-Lyzer
dialysis cassettes (Pierce). The resulting protein was concentrated
using Amicon Ultra Filter units (Millipore). Purity and yield of the
MBP fusion proteins were assessed by SDS-PAGE with Coomassie
staining and Bradford Assay (Thermo Fisher Scientific).
Bind-n-Seq
MBP-Miz-1-FL and MBP-Miz-1-ZF proteins at a range of
concentrations (Table 1) were bound to synthetic double-stranded
DNA (dsDNA) made from annealed random oligonucleotides with
barcodes in BnS binding buffer [0.12 mg/mL Herring Sperm
DNA, 100 mM ZnCl2, 5 mM DTT, 5% bovine serum albumin]
for 30 min with agitation at 25uC. Binding reactions were washed
6610 min with BnS wash buffer [10 mM Tris (pH 8.5), 100 mM
ZnCl2, 1 mM MgCl2, 5 mM DTT] under different KCl salt
concentrations (Table 1). Incubation with EB buffer (Qiagen)
containing 10 mM maltose was used to elute bound DNA
fragments. To determine the optimal number of amplification
cycles for each dsDNA pool, quantitative PCR was performed
using the Opticon Monitor system with SYBR green detection
(Program: 94uC for 4 min initial denaturation, 26 cycles of 94uC
for 30 sec, 63uC for 30 sec, and 72uC for 1 min). DNA was
amplified using iProof DNA Polymerase (Bio-Rad, Hercules, CA)
and purified using PCR Purification Kit (Qiagen). DNA yield was
quantified using a NanoDrop (Thermo Fisher Scientific), and
samples were pooled for sequencing. Amplified, pooled samples
with barcodes were sequenced using MiSeq (Illumina, San Diego,
CA), and reads were sorted and filtered for quality by the MiSeq
platform software.
Motif identification and comparison
De novo motif finding was performed as previously described
[16]. Sorted, filtered reads were analyzed in randomly sampled
clusters of 10,000 reads using MEME. Intermediate motifs were
matched back to the original dataset and subsequent rounds of
MEME were performed to generate the most enriched motifs for
each BnS condition.
To compare the identified motifs to known motifs, the Tomtom
motif comparison tool [17] was used to search a database of
human and mouse motifs [18] using representative position weight
matrices for Mizm1 and Mizm2, using the default significance
threshold (E-value ,10).
Motif finding in ChIP-seq data sets (GSE48602) was performed
using MEME-ChIP with the default parameters (zero or one
occurrences per sequence; width = 6–30 bp). ChIP-seq peak sets
were downloaded for two cell types: murine neural progenitor cells
(NPCs) and the human mammary epithelial cell line MDA-
MB231 (MDA cells). To identify instances of the motif in the Miz-
1 ChIP-seq peaks, the position-specific scoring matrices for these
motifs were obtained from MEME-ChIP and used as input to
FIMO using the default cutoff (p,1024). The motifs obtained
from MEME-ChIP were compared to the motifs identified by BnS
using Tomtom.
Electrophoretic Mobility Shift Assay (EMSA)
Probe sequences P1 and P2 were selected from the BnS
sequencing reads from MBP-Miz-1-FL and MBP-Miz-1-ZF,
respectively. For each probe, we selected a single sequencing read
containing the entire consensus sequence from the experimental
conditions that yielded the highest enrichment levels (barcodes
ACC and AGG). Control probe CP was designed using the
Random DNA Sequence generator (http://www.bioinformatics.
org/sms2/random_dna.html). Probes (P1, P2, and CP) labeled
with 59 IRDye 700 (Integrated DNA Technologies) were annealed
and used for EMSA. Binding reactions also included 100 ng/ml
poly(deoxyinosinic-deoxycytidylic) acid nonspecific competitor
(Sigma-Aldrich) in ZBA and were performed for 15 min at room
temperature. For competitive binding experiments, annealed
unlabeled probes were added to the binding reaction prior to
addition of labeled probe. Binding reactions were separated on 5%
Miz-1 Consensus DNA Binding Motif
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acrylamide gels in 0.5X Tris-borate buffer at 300 V for 60–90 min
at 4uC. After electrophoresis, acrylamide gels were visualized using
the Odyssey CLx imaging system (Licor), and results were
quantified when applicable using Licor ImageStudio software.
In vitro transcription/translation (IVTT)
IVTT was performed using the TNT Quick Coupled Tran-
scription/Translation System (Promega) according to the manu-
facturer’s instructions, using pCS2-hMiz vector or pCS2 empty
vector as a control. The reaction mix was supplemented with
1 mM additional alanine and glutamic acid to enhance the yield
by providing sufficient quantities of the most frequent amino acids
in the sequence of Miz-1.
Nuclear extracts
293T cells were cultivated in DMEM with 10% fetal bovine
serum (FBS). Cells were transfected with pCMV-SPORT6-CUX1
(Thermo Scientific) or empty vector using X-tremeGENE HP
(Roche). Two-to-three days after transfection, cells were harvested
for nuclear extracts by scraping in PBS. Cells were incubated for
10 min in swelling buffer (10 mM HEPES pH 8, 1.5 mM MgCl2,
10 mM KCl, 0.5 mM DTT, and protease inhibitors), then nuclei
were harvested in the same buffer plus 0.05% IGEPAL CA-630.
Nuclei were lysed by sonication in ZBA with 10% glycerol to
generate nuclear extracts.
Western blotting
Total protein was isolated using RIPA buffer and separated on
6–12% Bis-Tris gels (Invitrogen), then transferred to PVDF
membrane and blocked with 5% non-fat dry milk. Anti-Miz-1
(1:500; sc22837, Santa Cruz Biotechnology) was applied overnight
at 4uC. Where applicable, blots were then re-probed with anti-
beta-Actin (1:10,000; A1978, Sigma-Aldrich). Images were quan-
tified using ImageJ software.
Luciferase reporter assay
Luciferase reporter vectors were cloned starting with pGL3-
Enhancer vector (Promega). By chance, the pGL3-Enhancer
vector backbone initially contained the sequence ‘‘ATCGAT’’
upstream of the transcription start site; to produce the pGL3ec
control vector containing no potential Miz-1 binding motifs, this
sequence was removed by digestion with KpnI and BsgI, blunting,
and ligation. To produce vectors containing various putative Miz-
1 binding motifs, four repeats of the given motif were inserted
upstream of the luciferase gene between the KpnI and XhoI
restriction sites. For luciferase assays, HeLa cells were cultivated in
DMEM with 10% FBS. Cells were transfected using X-
tremeGENE HP with plasmids at a ratio of 20 ng Renilla
luciferase, 2 mg pGL3ec or pGL3e-MizM reporter, and 1 mg
expression vector [pBabe-Miz-1, pCS2-Miz-1, pCMV-Sport6-
Cux1, and/or pBabe empty vector]. To produce varied degrees of
Miz-1 overexpression, two different Miz-1 expression vectors were
used (pCS2, producing higher expression, and pBabe, producing
lower expression), and these vectors were diluted with empty
vector in varied ratios to produce different dosages of Miz-1.
Overexpression of human c-Myc was induced by transfection with
pRc/CMV-c-Myc. Overexpression of Miz-1 and c-Myc was
quantified by Western blot. Luciferase assays were performed in
96-well plates according to the manufacturer’s instructions using
the Dual-Luciferase Reporter Assay (Promega), and results were
quantified using a MicroBeta Luminescence Counter (Perkin
Elmer). Luciferase values were normalized to Renilla luciferase.
Statistical analysis
EMSA and luciferase experiments were performed at least in
biological triplicate. Numerical data are reported as means 6
standard deviations, and statistical significance was determined
using the Student’s t-test in Microsoft Excel (except where
otherwise noted in the text), with a cutoff of p,0.05 considered
significant. Statistical significance of motif similarity was computed
by Tomtom (motif-motif similarity) or FIMO (motif-sequence
similarity). Tomtom calculates E-values based on the likelihood of
seeing the observed amount of similarity between two motifs by
chance, corrected for multiple comparisons.
Results
Miz-1 expression and purification
We produced recombinant human Miz-1 full-length and zinc
finger domains (Miz-1-FL and Miz-1-ZF, respectively) using an
MBP tag for efficient purification by amylose-linked agarose beads
and subsequent elution with maltose (Figure 1A). SDS-PAGE and
Bradford Assay confirmed MBP-Miz-1-FL and -ZF purity and
concentrations of greater than 2 mM, important for subsequent
Table 1. BnS conditions and enrichment scores.
Barcode Protein [nM] Salt [mM] Highest Fold Enrichment
MBP-Miz-1-FL
ACA 50 1 17.417
ACC 50 50 20.867
ACG 50 100 14.125
ACT 5 100 9.808
AGA 350 100 11.162
MBP-Miz-1-ZF
AGC 50 1 25.053
AGG 50 50 26.2
AGT 50 100 16.421
ATA 5 100 19.6
ATC 120 100 10.75
doi:10.1371/journal.pone.0101151.t001
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implementation in the in vitro DNA binding assays (Figure 1B and
data not shown).
De novo motif identification
We identified Miz-1 binding motifs using BnS, a high-
throughput, in vitro DNA binding assay that allows for the
systematic and rapid detection of DNA binding motifs in parallel.
Short, randomly generated oligonucleotides (21 bp binding region)
with barcodes were used to generate double stranded DNA
fragments that were then bound to MBP-protein constructs and
amylose-linked agarose beads, washed and eluted with maltose
and identified by massively parallel sequencing to generate
approximately 100,000 reads per sample [16]. In this study,
MBP-Miz-1-FL and MBP-Miz-1-ZF (including Miz-1 zinc finger
residues 269–793) were each analyzed by BnS across five different
binding buffer and wash buffer conditions (Table 1). Highly
enriched consensus sequence motifs were identified for the full-
length (Figure S1) and zinc-finger (Figure S2) constructs. These
motifs had significant enrichment of greater than 5-fold and up to
25-fold over background, with hundreds of matching kmers
identified in most binding conditions. For both the full-length and
zinc-finger proteins, the highest enrichment was observed at
conditions of moderate protein concentration and moderate
washing stringency (50 mM salt concentration).
Across all binding conditions, every enriched motif had a
consensus sequence similar to either ‘‘ATCGGTAATC’’ or
‘‘ATCGAT’’, so we designated these motifs Mizm1 and Mizm2,
respectively (Figure 1C). The sequence ‘‘GATTACCGAT’’, found
repeatedly in the BnS results, is precisely the reverse complement
of Mizm1. Of note, Mizm2 is nearly a subsequence of Mizm1,
differing by only one base from the first six consensus bases of
Mizm1. When Miz-1-FL was used for BnS, Mizm1 was
represented more frequently than Mizm2 in the results (14/25
BnS motif hits contained Mizm1, Figure 1D), while Mizm2 was
enriched more frequently than Mizm1 when Miz-1-ZF was used
(20/25 BnS motif hits contained Mizm2, Figure 1D). The average
enrichment scores for the BnS enriched motifs followed a similar
trend, with Mizm1 having a slightly higher average enrichment
than Mizm2 in the case of Miz-1-FL, while Mizm2 was slightly
more enriched than Mizm1 in the case of Miz-1-ZF (Figure 1E);
however, these differences were not statistically significant.
Figure 1. BnS identifies Miz-1 preferred DNA binding motifs. (A) Structure of full length (MBP-Miz-1-FL) and zinc finger domain (MBP-Miz-1-
ZF) fusion proteins. MBP-Miz-1-ZF retains the Myc interacting region but not the BTB/POZ domain. (B) Robust expression of purified recombinant
MBP tagged proteins was observed at the expected ,130 kDa size; purification of MBP-Miz-1-FL is shown. Molecular weight standards are labeled in
kDa. (C) BnS was performed using MBP tagged proteins, yielding two main motifs, Mizm1 and Mizm2. (D) Ratio of Mizm1-like to Mizm2-like motifs
occurring in the list of top 25 BnS hits. (E) Box plot of enrichment scores for Mizm1-like and Mizm2-like motifs identified by BnS.
doi:10.1371/journal.pone.0101151.g001
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EMSA validates the binding of Miz-1 to the identified
motifs
We employed EMSA to directly assess the affinity of Miz-1
protein for the motifs Mizm1 and Mizm2. Probes were designed
by selecting reads from the highest-scoring BnS condition for each
protein (Table 2). Probes were selected to contain the consensus
sequences Mizm1 (P1) and Mizm2 (P2), using the 21 bp binding
region plus the 3 bp barcode that precedes the binding region in
the BnS library (ACC for P1, AGG for P2) to generate 24 bp
EMSA probes. Note that P2 contains an incomplete second copy
of Mizm2, also highlighted. The control probe (CP) was designed
using a random sequence generator. Mutant probes (P1m1, P1m2,
P2m1, and P2m2) were generated by altering 2–4 of the most
conserved bases within the consensus sequence, while an
additional mutant probe (P1m3) was designed by selecting a read
from the BnS results that contained the same Mizm1 consensus
sequence but a different surrounding sequence. Probes labeled
with IRDye700 (P1, P2, and CP) were used to allow infrared
detection. P1 and P2 were bound and shifted in the gel in the
presence of MBP-Miz-1-FL or MBP-Miz-1-ZF (Figure 2A, lanes 2,
3, 5, and 6), while CP was not bound (lanes 8 and 9). Unfused
control MBP alone failed to shift any of the probes (lanes 1, 4, and
7), indicating that the observed effect is due to Miz-1 itself and not
due to the MBP fusion. Of note, Miz-1-ZF is missing the POZ
domain required for Miz-1 homodimerization [19,20], suggesting
that dimerization may not be strictly required for binding to
Mizm1 and Mizm2. Figure 2A utilized bacterially expressed Miz-1
with an MBP tag, which could affect DNA binding specificity. In
order to address this and further validate the specific binding of
Miz-1 to Mizm1 and Mizm2, we used IVTT to produce wildtype
untagged Miz-1 protein, which was validated by Western blot
(Figure 2B). Untagged Miz-1 protein bound both P1 and P2 in
EMSA assays, but did not bind CP (Figure 2C). The relative
preference of Miz-1 for P1 vs. P2 was altered by the presence of
the MBP tag: MBP-tagged Miz-1 binds roughly equally to P1 and
P2 (Figure 2A), while untagged Miz-1 shows a stronger preference
for P1 and a lower affinity for P2 (Figure 2C).
Competitive EMSA demonstrates specificity of the
binding motifs
To investigate the specificity of the interaction between Miz-1
and its binding motifs, we added various unlabeled probes as
competitors to EMSA binding reactions before adding labeled
Figure 2. EMSA validates binding of labeled P1 and P2 to full-length Miz-1 and its zinc finger domain, with or without MBP tag. (A)
MBP-Miz-1-FL and MBP-Miz-1-ZF bind P1 and P2. MBP alone does not bind either probe, and Miz-1 does not bind the labeled control probe. (B)
Untagged Miz-1 (not containing the MBP tag) was produced by IVTT of pCS2-hMiz-1 vector. Molecular weight standards are labeled in kDa. (C)
Untagged Miz-1 binds and shifts labeled P1 and P2, but not CP. EV = empty vector (IVTT reaction using pCS2 vector backbone).
doi:10.1371/journal.pone.0101151.g002
Table 2. Probe sequences used in EMSA experiments.
Probe Sequence
P1: GA ATT ATC GGT AAT CCA TCG AGG T
P1m1: GA ATT AGG AGT AAA CCA TCG AGG T
P1m2: GA ATT ATC CGT AAT GCA TCG AGG T
P1m3: AC CCT TAT ATC GGT AAT CGG TAA G
P2: AGG GTT GGT ATC GAT TAT CGA GTT
P2m1: AGG GTT GGT ATC AAT TAT CTA GTT
P2m2: AGG GTT GGT ATG GAT TAA CGA GTT
CP: CAA AAG TGC GGC TGC GTG GTG CAC
The motifs Mizm1 (probe P1) and Mizm2 (probe P2) are underlined, while
mutations are bolded.
doi:10.1371/journal.pone.0101151.t002
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probe. The probe-protein complex was effectively disrupted by
addition of 200-fold excess of unlabeled matched probe in the
binding reactions (Figure 3, lane 1 vs. 2 and lane 8 vs. 12 in each
panel, p,0.001). Unlabeled P1 and P2 both effectively out-
competed labeled P1 or P2 in complex formation with MBP-Miz-
1-FL (Figure 3A-B) or MBP-Miz-1-ZF (Figure 3C-D). However,
the extent of competition in any one given condition depended on
which labeled and unlabeled probes were used. For example, in
the context of MBP-Miz-1-FL (Figure 3B), mixing unlabeled P1
with labeled P1, unlabeled P2 with labeled P2, and unlabeled P1
with labeled P2 reduced the amount of bound labeled probe by
5.3, 6.4, and 4.8 fold, respectively (lanes 2, 9, and 12 vs. lane 1).
However, mixing unlabeled P2 with labeled P1 resulted in only a
2.0-fold reduction in binding of the labeled probe (lane 5 vs. lane
1). We observed the same trend when the binding reaction
contained MBP-Miz-1-ZF rather than MBP-Miz-1-FL: unlabeled
P2 was less able to compete with labeled P1 (lane 5 vs. lane 1)
compared to the three other combinations of labeled and
unlabeled probes (lanes 2, 9, and 12 vs. lane 1). These data
suggest that the affinity of P1 for Miz-1 may be greater than that of
P2.
Mutant unlabeled probes were generated containing two-to-
four alterations in highly conserved bases from the motif
sequences. When these were used in competitive EMSA binding
reactions, their ability to block binding of Miz-1 to the labeled
probe was significantly attenuated (p,0.05 compared to un-
mutated competitor). One example is the binding of MBP-Miz-1-
ZF to labeled P1, with unlabeled P1, P1m1, or P1m2 as
competitors (Figure 3C-D, lanes 1–4). The addition of unlabeled
P1 to the reaction (lane 2) caused an 87% reduction in binding of
MBP-Miz-1-ZF to labeled P1 as determined by the relative
intensity of the shifted bands, but mutating four or two bases of P1
to generate P1m1 and P1m2 competitors (lanes 3 and 4) nearly
eliminated the ability of the unlabeled probe to compete for
binding (7% reduction for P1m1, 24% reduction for P1m2,
compared to no competitor). By comparison, an additional mutant
probe, P1m3, was generated that contains Mizm1 with an entirely
different surrounding sequence. This probe was still able to
efficiently compete with P1 and P2 in binding both MBP-Miz-1-
FL and MBP-Miz-1-ZF (35–55% reduction in binding compared
to no competitor; Figure 4), indicating that the motif sequence
itself is sufficient for effective Miz-1 binding.
Luciferase reporter assays demonstrate a positive effect
of Miz-1 on gene expression
We next examined whether Miz-1 could regulate gene
expression by binding to DNA containing the novel consensus
motif sequences. We first inserted three different sequences
upstream of the luciferase gene in a pGL3-enhancer reporter
vector: repeats of both the Mizm1 and Mizm2 consensus motifs
Figure 3. Excess unlabeled probes compete with labeled probes to bind MBP-Miz-1-FL (A-B) or MBP-Miz-1-ZF (C-D). Addition of 200-
fold excess unlabeled P1 or P2 abrogates binding of Miz-1-FL or Miz-1-ZF to labeled P1 or P2 (lanes 2 and 5 vs. lane 1; lanes 9 and 12 vs. lane 8).
Mutating two to four critical residues in the probe sequences (P1m1, P1m2, P2m1, or P2m2) reduces their ability to compete with labeled probe for
binding (lanes 3 and 4 vs. lane 2; lanes 6 and 7 vs. lane 5; lanes 10 and 11 vs. lane 9; lanes 13 and 14 vs. lane 12). Representative images are shown (A,
C), along with quantification of three replicate experiments (B, D). * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0101151.g003
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with no additional context (pGL3e-Mizm), Mizm1 in the context
of P1 (pGL3e-Mizm1), or Mizm2 in the context of P2 (pGL3e-
Mizm2; Figure 5A). Each of these reporter constructs was
transfected into HeLa cells with or without overexpression of
Miz-1 (Figure 5B), revealing a 13 to 15-fold activation of luciferase
activity in the presence of any of the three Miz-1 binding motif
sequences. Despite the differing affinity of Miz-1 for the two motifs
observed by EMSA, Miz-1 is equally capable of inducing
transcription through either motif, suggesting that the observed
affinity of Miz-1 for P2 is sufficient for productive, transcription-
inducing binding in vivo.
We predicted that a few specific bases shared by the pGL3e-
Mizm, -Mizm1, and -Mizm2 vectors could be critical for Miz-1
binding. To test this hypothesis, we constructed luciferase
reporters containing two, three, or five mutations in the Mizm1
sequence (Figure 5C). Luciferase reporter assays demonstrated
that mutating as few as two bases in the Mizm1 sequence is
sufficient to entirely eliminate the ability of Miz-1 to activate gene
expression (Figure 5D).
To examine whether c-Myc might synergize with Miz-1 to
activate or repress gene expression in this motif-driven context,
given the known ability of the two proteins to bind each other, we
conducted luciferase assays in the presence of both proteins.
Overexpression of c-Myc produced a small, statistically significant
increase in luciferase reporter expression regardless of the presence
or absence of Miz-1 or the Miz-1 binding motif (Figure 5E),
indicating a general non-specific enhancement of luciferase
expression rather than any synergistic effect with Miz-1.
We also investigated the dose-dependence of the transcriptional
activation. The pGL3e-Mizm reporter vector was transfected into
HeLa cells along with a range of ratios of Miz-1 expression vector
to empty vector, in order to generate varied doses of Miz-1
overexpression. A statistically significant, dose-dependent increase
in reporter expression was observed with levels of Miz-1 protein
overexpression ranging from ,5-fold to over 300-fold (Figure 6A-
B). These effects on gene expression were dependent on presence
of the motif sequence; expression of luciferase from the pGL3ec
vector lacking the motif sequences was unaffected by addition of
Miz-1 (Figure 6A). In separate experiments, we also examined
reporter expression in the context of lower relative overexpression
of Miz-1 (2- to 6-fold overexpression as determined by Western
blot), which may be a more physiologically relevant amount of
Miz-1 expression (Figure 6C-D). In this mild overexpression
context, a statistically significant increase in reporter expression
was also evident at levels of Miz-1 expression less than 3-fold
higher than that found in untreated HeLa cells (p,0.05).
Figure 4. The sequence surrounding the core motif Mizm1 is dispensable for Miz-1 binding.When the sequence surrounding the Mizm1
motif is mutated (P1m3), the unlabeled probe retains its ability to compete with labeled probe P1 or P2 to bind MBP-Miz-1-FL (A-B) or MBP-Miz-1-ZF
(C-D). Representative images are shown (A, C), along with quantification of three replicate experiments (B, D). * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.pone.0101151.g004
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Miz-1 binding motifs resemble CUT homeodomain
motifs
Position weight matrices for Mizm1 and Mizm2 (Figure 1C)
were used as input into the Tomtom motif comparison tool in
order to identify any known motifs with similarity to the Miz-1
motifs that we characterized earlier, using a database of human
and mouse transcription factor binding sites. Tomtom identified
14 motifs significantly similar to Mizm1 and 14 motifs similar to
Mizm2 (Table 3; E-value ,10). A strikingly high number of
transcription factors containing the CUT homeodomain were
represented in the Tomtom results: 29% of the matches for Mizm1
(4 of 14) and 64% of the matches for Mizm2 (9 of 14) were
members of the CUT homeodomain family. Most CUT
homeodomain proteins have the consensus sequence ATCGAT
as the core of their binding motif, which aligns with the Miz-1
binding motifs we have identified (Figure 7A).
Miz-1 and Cux1 have differential preferences for Mizm1
and Mizm2
We hypothesized that if Miz-1 and CUT homeodomain
proteins bind similar motifs, they may compete to bind the same
DNA sequences in cells and have some unknown inter-related
function. To begin to test this hypothesis, we focused on the most
well-studied member of the CUT homeodomain protein family,
Cux1, which binds the consensus sequence ATCGAT [21]. To
determine whether Cux1 is likely to compete with Miz-1 to bind
the same sequences, we produced nuclear extracts from 293 T
cells transfected with Cux1 or empty vector as a control. Multiple
Cux1 bands including the p200 and p110 isoforms were detected
by Western blot (data not shown), in accordance with previous
studies indicating that Cux1 is proteolytically processed to
generate multiple different isoforms with higher DNA-binding
affinity [22,23]. When these nuclear extracts were used in EMSA
assays, both Miz-1 and Cux1 bound P1 and P2 but not CP
(Figure 7B). We observed that Miz-1 bound P1 more strongly than
P2, while Cux1 bound P2 more strongly than P1. Quantification
of EMSA bands validated this observation (Figure 7C): the
intensity of the probe shifted by Miz-1 was approximately 2.5-fold
higher for P1 than for P2, while the intensity of the probe shifted
by Cux1 was approximately 2-fold higher for P2 than for P1. In
agreement with the concept that Cux1 preferentially binds
Mizm2, luciferase assays demonstrated that Cux1 represses
Figure 5. Luciferase reporter assays in HeLa cells demonstrate that Miz-1 activates gene expression via Mizm1. (A) Four luciferase
reporter vectors were constructed: pGL3ec containing no putative Miz-1 binding motifs, pGL3e-MizM containing four repeats of both the Mizm1 and
Mizm2 motifs upstream of the transcription start site, pGL3e-Mizm1 containing four repeats of the P1 probe sequence, and pGL3e-Mizm2 containing
four repeats of the P2 probe sequence. (B) Miz-1 overexpression in HeLa cells produces a statistically significant increase in luciferase reporter activity
with all of the three reporter vectors containing putative Miz-1 binding motifs. (C) Three mutant luciferase reporter vectors were constructed,
containing two (Mizm1mut2), three (Mizm1mut3), or five (Mizm1mut5) changes in highly conserved bases of the motif. (D) Miz-1 overexpression
produces a statistically significant increase in luciferase reporter activation in the presence of Mizm1, but the effect is eliminated by mutating as few
as two bases in the motif. (E) Overexpression of c-Myc does not synergize with Miz-1; instead, c-Myc overexpression produces a statistically significant
increase in luciferase activity for all conditions: with or without Miz-1 overexpression, and with or without the presence of Miz-1 binding motifs.
Luciferase expression was normalized to expression of the Renilla luciferase control reporter vector and to luciferase expression in untreated HeLa
cells. * p,0.05; ** p,0.01; *** p,0.001. EV = empty vector control; RC = reverse complement.
doi:10.1371/journal.pone.0101151.g005
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luciferase expression from pGL3e-Mizm1 and pGL3-Mizm2, the
two reporter constructs containing the sequence ‘‘ATCGAT’’
(Figure 7D). Cux1 did not repress gene expression from pGL3e-
Mizm1, which does not contain the sequence ‘‘ATCGAT’’,
suggesting that Cux1 depends on the presence of that specific
hexamer sequence for its transcriptional function. These experi-
ments demonstrate that while Miz-1 and Cux1 indeed bind very
similar motifs, they each have a unique preferred motif and likely
do not directly compete to bind the same genomic motifs in vivo.
Miz-1 ChIP-seq data reveals enrichment of motifs similar
to Mizm1 and Mizm2
A study from Wolf, et al. was recently published containing
global genomic binding profiles for Miz-1 in two cell types,
obtained by ChIP-seq [15]. We retrieved the Miz-1 peak data
from the NCBI Gene Expression Omnibus and submitted it to
MEME-ChIP to identify motifs in the data. Wolf, et al. reported
the top motif returned by MEME-ChIP in the murine sample: a
long, relatively permissive motif with no resemblance to Mizm1 or
Mizm2 that we designate NPCm1 (Figure 8A). However, when we
repeated and extended the previous analysis of this data, we found
that the second motif returned by MEME-ChIP for the murine
NPC data (NPCm2), as well as the top motif returned for the
human MDA cell data (MDAm), are also very highly enriched,
with E-values of 8.2610229 and 1.106102195, respectively. These
motifs are quite different from NPCm1 and are nearly identical to
each other, as determined by Tomtom (Figure 8B; p=8.8610210).
The central portions of MDAm and NPCm2 are also significantly
similar to the motif Mizm1 as determined by Tomtom (Figure 8C;
p=0.009).
We used FIMO to identify instances of MDAm in both the
NPC and MDA peak sets; MDAm was present in 60.2% of peaks
in the mouse data set and 29.7% of peaks in the human data set
(Figure 8D). We also used FIMO to identify instances of Mizm1 in
the ChIP-seq peak sets (Figure 8E). Mizm1 was present in a lower
fraction: 16.1% of peaks in the mouse data and 9.5% of peaks in
the human data. The prevalence of MDAm in both peak sets
suggests relatively high in vivo relevance of this motif; the lower
prevalence of Mizm1 suggests that the binding specificity of
physiologically expressed Miz-1 in its native genomic context may
differ at least somewhat.
An important next step would be to determine whether the
ChIP-seq peaks containing these motifs could be validated by
ChIP-qPCR. We reasoned that due to the high prevalence of
MDAm in the peak sets, some of the peaks that were already
validated by Wolf et al. might contain the motifs. Therefore we
used the UCSC In Silico PCR tool to identify the sequences
amplified by the qPCR primers given in the supplemental material
accompanying the paper, and we used FIMO to search for
instances of the motifs in the regions that were amplified by ChIP-
qPCR. Indeed, FIMO identified sequences matching MDAm in
four of the 10 peaks that Wolf et al. validated by ChIP-qPCR,
including Rorc (Figure 8F). Similarly, FIMO identified sequences
matching Mizm1 in 4 of the 10 peaks, including Vps28 (Figure 8F).
This result validates Miz-1 binding to genomic regions containing
MDAm and Mizm1.
Intriguingly, we noted that the Rorc1 luciferase reporter vector
constructed by Wolf et al. also contains an excellent match to
MDAm (p=6.6161027, determined by FIMO). This raises the
possibility that the active sequence in the Rorc1 luciferase vector
could actually be MDAm rather than NPCm. The researchers
observed approximately 8–20-fold activation of the reporter by
Miz-1, which is similar to the level we observed using reporter
vectors that contain Mizm1. Overall, this reporter data along with
the strong agreement between the in vitro BnS data and the in vivo
MEME-ChIP data provides robust support for the functional
importance of these motifs in directing Miz-1 recruitment to DNA.
Figure 6. Miz-1 overexpression produces a dose-dependent increase in luciferase reporter expression at high-range (A-B) and low-
range (C-D) Miz-1 dosages, while luciferase expression from pGL3ec vector is unaffected by Miz-1. Miz-1 relative protein expression (x-
axis in A and C) was determined by quantification of Western blots (representative images shown in B and D) using Image J, and was normalized to
beta-actin and to expression in control untransfected HeLa cells. * p,0.05; ** p,0.01; *** p,0.001.
doi:10.1371/journal.pone.0101151.g006
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Miz-1 ChIP-seq peaks containing MDAm are
predominantly located outside of proximal promoter
regions
Miz-1 has previously been reported to bind Inr sequences near
transcription start sites (TSS) that do not resemble the motifs we
describe in this report. We hypothesized that motif-dependent
binding of Miz-1 may represent an Inr-independent form of
binding that is less likely to be localized in proximal promoter
regions, but rather occurs in gene bodies, enhancers, or other
regions. To test this hypothesis, we generated density plots of Miz-
1 ChIP-seq peak locations with respect to the nearest TSS
(Figure 9A-B). In both NPCs and MDA cells, peaks without motifs
are highly concentrated near the TSS, while peaks with MDAm
motifs are distributed broadly throughout more distal regions. In
the NPC peak set, 36.7% of peaks containing MDAm occur within
1.5 kb of a TSS, while 60% of peaks without MDAm occur in the
same interval. Similarly, in the MDA peak set, 14.8% of peaks
containing MDAm occur within 1.5 kb of a TSS, while 33.2% of
peaks without MDAm occur in the same interval. These
differences are statistically significant (p=9.961025 for NPC peak
set, p,2.2610216 for MDA peak set; Chi-squared test).
We repeated the analysis, this time using Homer’s classification
of peaks into genome regions rather than distance from TSS as the
metric (Figure 9C-D). Again, peaks without motifs were more
likely to be found in promoter regions in both cell types (p,
0.0001; Chi squared test). Peaks containing MDAm were enriched
in introns and intergenic regions, which, in this classification
scheme, includes genomic features like enhancers.
Figure 7. Cux1 binds a similar, but not identical, motif to that identified for Miz-1. (A) Tomtom was used to identify motifs similar to
Mizm1 and Mizm2. Alignments are shown between known Cut homeodomain binding motifs and Mizm1 or Mizm2. (B) EMSA reveals that Miz-1
preferentially binds Mizm1 (lane 2 vs. lane 5), while Cux1 preferentially binds Mizm2 (lane 3 vs. lane 6). One representative image is shown (B), along
with quantification of three replicate experiments (C). Relative binding intensity of Miz-1 and Cux1 to P1 versus P2 in (C) is defined as the intensity of
bound probe in lane 2/lane 5 for Miz-1, and lane 3/lane 6 for Cux1. (D) Cux1-overexpressing HeLa cells show a decrease in luciferase activity when the
core Cux1 binding motif (ATCGAT) is present in the reporter vector, but not when the reporter vector contains Mizm1, which does not contain
ATCGAT. * p,0.05; ** p,0.01; *** p,0.001.
doi:10.1371/journal.pone.0101151.g007
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Table 3. Motifs with significant similarity to Mizm1 and Mizm2 identified using Tomtom.
Mizm1 Mizm2
Matching motif p-value Matching motif p-value
ERG_full_2 0.0027 CUX2_DBD 0.0003
FLI1_full_2 0.0031 CUX2_DBD_2 0.0004
ERG_DBD_2 0.0034 PAX7_full 0.0005
CUX1_DBD 0.0034 CUX1_DBD_3 0.0006
VENTX_DBD_2 0.0035 PAX3_DBD 0.0009
FLI1_DBD_2 0.004 CUX1_DBD_2 0.0009
HESX1_DBD_2 0.0048 CUX1_DBD 0.001
LHX9_DBD_2 0.0083 ONECUT1_full 0.001
ONECUT2_DBD 0.0089 ONECUT2_DBD 0.001
FLI1_DBD 0.0093 PAX7_DBD 0.0014
CUX2_DBD 0.0098 ONECUT1_DBD 0.0019
ONECUT1_full 0.0105 ONECUT3_DBD 0.0052
ERG_DBD 0.0119 VENTX_DBD 0.0074
IRF7_DBD_2 0.0126 IRF7_DBD_2 0.008
Cut-homeodomain family members are in bold.
doi:10.1371/journal.pone.0101151.t003
Figure 8. Motifs enriched in Miz-1 ChIP-seq peaks match Mizm1. (A) The top-scoring peak in NPCs, as reported by Wolf et al., has little similarity to
Mizm1. (B) Tomtom alignment of the top-scoringmotif inMDA peaks (MDAm)with the second-top scoringmotif in NPC peaks (NPCm2), demonstrating that
they are nearly identical to each other (p=8.8610210). (C) Tomtom alignment of Mizm1 with the central portion of MDAm, showing statistically significant
similarity (p=0.009). (D) FIMOwas used to identify ChIP-seq peaks containing instances of MDAm in the NPC (left) andMDA (right) Miz-1 ChIP-seq peak sets,
using a cutoff of p,0.0001. (E) FIMO was used to identify ChIP-seq peaks containing instances of Mizm1 in the NPC (left) and MDA (right) Miz-1 ChIP-seq
peak sets, using a cutoff of p,0.0001. (F) FIMOwas used to search the ChIP-seq peaks that Wolf et al. validated by ChIP-qPCR for matches to the MDAm and
Mizm1 motifs. Examples of statistically significant matches are shown (p=1.761027 for MDAm in RORC-TSS; p=1.2261025 for Mizm1 in Vps28-TSS).
doi:10.1371/journal.pone.0101151.g008
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Discussion
In this work we have defined and validated a novel preferred
DNA binding motif for the zinc finger transcription factor Miz-1
using BnS with both the full length Miz-1-FL and extended zinc
finger domain Miz-1-ZF protein constructs. Miz-1-ZF retains
some ability to bind Mizm1/Mizm2 despite loss of the N-terminal
268 amino acids of Miz-1, including the BTB/POZ domain,
although the level of binding appears slightly lower. This suggests
that dimerization through the POZ domain is not strictly required
for DNA binding. Instead, the extended zinc finger domain
encompassing most of the protein is likely responsible for binding
the DNA motif, in accordance with the known DNA binding
function of C2H2 zinc fingers. The structures of Miz-1 zinc fingers
5–8 [24] and 8–10 [25] have been solved, and it is also possible to
predict the binding specificity of all 13 ZFs from their sequences:
59-A(T/C)C NAG (G/T)CN NNA N(T/C)A GTC GAT NAA
G(T/C)C GAT NNT NTC GA(T/C)-39 [25]. However, this
predicted binding specificity has little obvious similarity to the
motifs we identified experimentally, or to the motif identified by
Wolf, et al., suggesting that motif prediction from the protein’s
sequence may not reflect the protein’s DNA sequence affinity.
BnS analysis may tend to identify only high affinity DNA motifs,
while there may be several motifs for a given protein based on its
structural conformation that vary in affinity, but nonetheless are
functionally relevant. The consensus motifs identified for Miz-1,
Mizm1 and Mizm2, were both highly enriched over background
and were further analyzed for their ability to be bound by Miz-1
protein in vitro. EMSA analysis confirmed Miz-1 binding to these
motifs, and demonstrated that altering as few as two bases is
sufficient to disrupt binding of Miz-1 to the motif sequence. The
affinity of Miz-1-FL for Mizm2 is much lower than its affinity for
Mizm1 when compared by EMSA; however, Miz-1 is equally
capable of inducing transcription through the two motifs in
luciferase assays. Additionally, the motifs identified by MEME-
ChIP are similar to Mizm1 and Mizm2 but longer, suggesting that
more of the zinc fingers of Miz-1 may be able to bind DNA in vivo
as compared to in a BnS assay.
Surprisingly, the recently published Miz-1 binding motif by
Wolf, et al. differs completely from the motifs we describe in this
report defined by both BnS and MEME-ChIP. Our results do not
necessarily contradict the previously reported motif NPCm1; Miz-
1 contains thirteen ZF motifs that could each have differing DNA
sequence specificities, making it possible that the Miz-1 protein
binds multiple independent motifs depending on the context. The
mechanism of action of polydactyl ZF proteins such as Miz-1 may
be quite different from those that contain only a few ZF and may
rely more on protein-protein interactions. In most multi-finger
proteins, which can have more than 35 fingers, only 3–5 fingers
Figure 9. Analysis of ChIP-seq peak locations with respect to genes. (A-B) Peaks lacking MDAm are highly concentrated within 1 kb of the
TSS in the ChIP-seq data sets from MDA cells (A) and NPCs (B), while in both cases, peaks containing MDAm are less likely to be localized near the TSS.
Density plots were generated in R using the ggplot2 package; peaks occurring more than 50 kb from the nearest TSS were plotted at +/250 kb. (C-D)
Homer annotations of peak locations for ChIP-seq peaks from MDA cells (C) and NPCs (D). The promoter is defined as 21 kb to +100 bp surrounding
the TSS; TTS (transcription termination site) is defined as2100 bp to +1 kb surrounding the TTS. Peaks containing MDAm were identified using FIMO,
and the distance to nearest TSS and gene-centered annotations were determined using Homer with all RefSeq human (A, C) or mouse (B, D) genes.
*** p,0.0001 (Chi-squared test).
doi:10.1371/journal.pone.0101151.g009
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are usually involved in DNA binding; the others may be involved
in RNA or protein binding, and in some cases may even have
overlapping functions [26,27]. An additional potential complica-
tion is that motif-driven binding of Miz-1, such as binding to
Mizm1 and Mizm2, likely represents only a subset of Miz-1
binding in vivo. Miz-1 has numerous binding partners such as Myc
that also can themselves bind to DNA or chromatin and in so
doing may tether Miz-1 to the genome, which may account for a
substantial fraction of its genomic binding, depending on the cell
type, and alter DNA sequence recognition.
Understanding the genomic binding of Miz-1 may shed light on
cancer and stem cell related gene expression programs co-
regulated by Miz-1 and Myc. Miz-1 binds initiator sequences in
the core promoters of target genes thereby modulating their
expression [1,13,28]. The two existing studies of global genomic
Miz-1 binding differ substantially in the proportion of Miz-1
binding reported to occur in proximal promoters vs. farther from
transcription start sites [9,15], suggesting possible context-depen-
dent differences in the global DNA binding pattern of Miz-1.
Functionally, Miz-1 expression correlates with favorable outcomes
in neuroblastoma [6,29], while excess Myc functions as a potent
oncoprotein [30], suggesting a possible antagonistic relationship
between Miz-1 and Myc in cancer. However, in some cases Myc
and Miz-1 can work in concert to promote tumorigenic functions
[31], suggesting that their relationship is much more complex than
simple antagonism. We have postulated that Miz-1 may tether its
binding partners, including Myc, to the genome through binding
to specific DNA motifs such as Mizm1 and Mizm2. However, we
did not observe a synergistic effect of c-Myc on Miz-1-driven
reporter activity. At least in the cell culture context that we have
examined, this suggests that Miz-1 may bind through Mizm1 and
Mizm2 independent of Myc to activate transcription.
The Miz-1 binding motifs we identified are strikingly similar to
the known transcription factor binding motif for the homeobox
protein CDP/Cux1 (TRANSFAC M00104), which includes the
consensus sequence ATCGAT [21]. This suggests the possibility
that Cux1 and Miz-1 could potentially compete for genomic
binding. Cux1 is proteolytically cleaved to form a p110 isoform
with stronger DNA binding affinity [21]. In agreement with the
idea that proteolytic cleavage is required for strong DNA binding
by Cux1, we used IVTT to produce full-length Cux1 for EMSA
experiments, but the un-cleaved Cux1 product failed to bind
detectable levels of Mizm1 or Mizm2 (data not shown). In
contrast, Cux1 produced in 293T cells was cleaved to form
multiple smaller isoforms observed by Western blot, and robustly
bound Mizm2 in EMSA assays. Overall, the data suggest that
despite the sequence similarity between the two proteins’ motifs,
Miz-1 and Cux1 are unlikely to compete for the same sequences in
vivo due to their differing preference for Mizm1 vs. Mizm2.
However, we cannot at this point rule out the possibility that the
two proteins may, in some context, compete to bind the same
motif.
In this work, we used BnS to define potential direct DNA
binding functions of Miz-1. The novel motifs that we have
identified may guide localization of Miz-1 in vivo, where it can
recruit from its extensive host of binding partners to regulate gene
expression and ultimately cell fate. Future work including
additional genomics studies will help to further characterize how
Miz-1 functions on chromatin.
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